Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.small Co.2 Regulatory News (BSC)

Share Price Information for Br.small Co.2 (BSC)

Share Price is delayed by 15 minutes
Get Live Data
50.55    0.00 (0.00%)
Bid:
49.60
Ask:
51.50
Spread: 1.90 (3.831%)
Market Cap: £193.32m
BSC Live PriceLast checked at - London Stock Exchange

Intraday Br.small Co.2 Share Chart

Interim Management Statement

9 May 2018 09:54

RNS Number : 4926N
British Smaller Companies VCT2 Plc
09 May 2018
 

 

British Smaller Companies VCT2 plc

Interim Management Statement

For the quarter ended 31 March 2018

British Smaller Companies VCT2 plc (the "Company") presents its interim management statement for the quarter ended 31 March 2018. The statement also includes relevant financial information between the end of the quarter and the date of this statement. A copy of this interim management statement can be found at www.bscfunds.com.

Overview

The Company has continued to make progress in the quarter with total return rising to 114.7 pence per ordinary share. This is an increase of 0.4 pence per ordinary share.

It is pleasing that improved performance across a number of investments contributed to the £0.5 million increase in Net Asset Value ("NAV") from the portfolio in the period.

A number of investments were being held up due t0 delays in HMRC's advance assurance process, but these have now been received, allowing the Company to have a strong start to the year, with investments totalling £4.3 million to date and a successful fundraising. The Company launched a top-up fundraising on 11 January 2018 which was fully subscribed from existing shareholders, closing on 26 January 2018 and raising net proceeds of £4.3 million.

Performance

31 March 2018

Movement

31 December 2017

Net Assets (£m)

63.6

4.5

59.1

NAV per share (PPS)

59.2p

0.4p

58.8p

Cumulative dividends paid (PPS)

55.5p

-

55.5p

Total Return (PPS)

114.7p

0.4p

114.3p

Shares in issue

107,442,275

6,951,700

100,490,575

 

The total return at 31 March 2018, calculated by reference to the NAV per ordinary share and the cumulative dividends paid per ordinary share, was 114.7 pence per ordinary share compared to 114.3 pence per ordinary share at 31 December 2017. Cumulative dividends paid were unchanged at 55.5 pence per ordinary share (31 December 2017: 55.5 pence per ordinary share).

The unaudited NAV per ordinary share as at 31 March 2018 was 59.2 pence per ordinary share (31 December 2017: 58.8 pence per ordinary share) representing an increase of 0.4 pence per ordinary share primarily from the net upward movement in the overall portfolio valuation.

Dividends and shares in issue

On 16 February 2018 the Company issued 7,366,700 ordinary shares as part of the top-up fundraising, raising net proceeds of £4.3m.

On 27 March 2018 the Company purchased 415,000 ordinary shares of 10 pence each at a price of 56.36 pence per ordinary share. These shares were placed in treasury.

The number of ordinary shares in issue at 31 March 2018 was 107,442,275 (31 December 2017: 100,490,575). In addition, at 31 March 2018 the Company held 4,421,351 ordinary shares in treasury (31 December 2017: 4,006,351).

 

Net assets

Net assets at 31 March 2018 comprised the following:

£000

% of net assets

Unquoted investments at fair value

41,951

65.9

Quoted investments at bid price

2,184

3.5

Total investments

44,135

69.4

Cash and cash equivalents

18,367

28.9

Other net current assets

1,126

1.7

Net assets

63,628

100.0

 

The investment portfolio at 31 March 2018 was comprised as follows:

Valuation

£000

Valuation as a % of net assets

Matillion Limited

3,292

5.2

Intelligent Office UK

3,246

5.1

ACC Aviation

3,119

4.9

Mangar Health Limited

2,771

4.4

KeTech Enterprises Limited

2,488

3.9

Eikon Holdco Limited

2,000

3.1

Gill Marine Holdings Limited

1,951

3.1

GTK (Holdco) Limited

1,933

3.0

Business Collaborator Limited

1,865

2.9

Springboard Research Holdings Limited

1,843

2.9

24,508

38.5

Other investments

19,627

30.9

Total investments

44,135

69.4

 

During the quarter to 31 March 2018 the Company made two new investments of £2.0 million into Eikon Holdco Limited, a leading end-to-end digital post-production services provider for the motion picture and broadcast industry and £1.0 million into Ncam Technologies Limited, a provider of innovative and leading Augmented Reality solutions for the entertainment industries. The Company also made a follow-on investment of £0.4 million into Matillion Limited as part of an £18 million series B fundraising that was supported by two US investors.

Since the end of the quarter the Company has invested £0.9 million into Hutchinson Networks Limited, a specialist in the provision of computer networking and data centre services.

In the quarter to 31 March 2018 the realisation and repayment of investments generated cash proceeds of £0.2 million.

Portfolio Performance

Over the quarter to 31 March 2018 the aggregate unrealised portfolio valuation has increased by £0.5 million.

The Board continues to follow its policy of maintaining a diversified portfolio. At 31 March 2018, only two investments represented more than 5 per cent of the Company's NAV.

Outlook

While the UK's economic performance remains subdued the Company's portfolio businesses have continued to adapt their business models and the new investment pipeline remains strong, as shown by the level of investment so far this year. HMRC's recently revised guidance on their advance assurance process could also help to improve the speed at which new investments are made.

As the latest investments show, the composition of the Company's portfolio is changing towards growth capital investments in earlier stage, younger businesses, while the success of the series B fundraising into Matillion demonstrates that the portfolio contains investments with good growth opportunities.

Your Board continues to manage the Company's portfolio in order to maximise the total return and smooth the transition to a period of expected greater volatility of returns through targeted new investments, selective realisations and periodic reviews of the Company's dividend and buy-back policies.

Your Board is committed to delivering long-term value to shareholders through a strong and diversified portfolio.

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

9 May 2018

For further information please contact:

David Hall YFM Private Equity Limited Tel: 0113 244 1000

Jonathan Becher Panmure Gordon (UK) Limited Tel: 0207 886 2715

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
QRFDMGGKRLLGRZG
Date   Source Headline
6th May 20267:00 amRNSDividend Declaration
20th Apr 202610:01 amRNSAdmission to Trading
1st Apr 20269:00 amRNSIssue of Equity
27th Mar 20264:12 pmRNSTransaction in Own Shares
23rd Mar 202610:45 amRNSPublication of a Supplementary Prospectus
19th Mar 20267:00 amRNSAnnual Financial Report
30th Jan 20267:00 amRNSAdmission of Further Securities to Trading
7th Jan 20269:31 amRNSDirector/PDMR Shareholding
7th Jan 20269:30 amRNSIssue of Equity
23rd Dec 20258:54 amRNSAmendments to AIFM Agreements
23rd Dec 20258:54 amRNSAmendments to AIFM Agreements
22nd Dec 20259:13 amRNSTransaction in Own Shares
22nd Dec 20259:13 amRNSTransaction in Own Shares
18th Dec 202512:14 pmRNSClose of Offers to new Applications
18th Dec 202512:14 pmRNSClose of Offers to new Applications
28th Nov 202510:00 amRNSInterim Management Statement
20th Nov 20259:00 amRNSOffer Update
31st Oct 202510:01 amRNSPayment of dividend and issue of Equity
10th Oct 20253:41 pmRNSOffer Update
2nd Oct 20259:00 amRNSOffer Update
25th Sep 20259:04 amRNSPublication of a Prospectus
23rd Sep 20257:00 amRNSTransaction in Own Shares
12th Sep 20257:00 amRNSHalf-year Report
22nd Aug 202510:45 amRNSNew combined offer for subscription
24th Jun 20257:00 amRNSTransaction in Own Shares
23rd Jun 202510:20 amRNSPayment of Dividend and Issue of Equity
13th Jun 20251:30 pmRNSInterim Management Statement
12th Jun 202510:46 amRNSResult of AGM
13th May 202512:54 pmRNSDividend Declaration
1st Apr 20258:02 amRNSDirector/PDMR Shareholding
1st Apr 20258:00 amRNSIssue of Equity
26th Mar 20255:15 pmRNSTransaction in Own Shares
24th Mar 202512:45 pmRNSPublication of Supplementary Prospectus
24th Mar 202512:45 pmRNSPublication of Supplementary Prospectus
18th Mar 20251:00 pmRNSAnnual Financial Report
30th Jan 20259:05 amRNSDirector/PDMR Shareholding
30th Jan 20259:00 amRNSIssue of Equity
27th Jan 20259:21 amRNSPayment of dividend and issue of shares
8th Jan 20252:14 pmRNSClose of Offer to new Applications
8th Jan 20252:13 pmRNSClose of Offer to new Applications
17th Dec 20242:13 pmRNSNominal Capital Reduction
17th Dec 20247:00 amRNSDividend Declaration
16th Dec 20245:08 pmRNSTransaction in Own Shares
29th Nov 20249:00 amRNS3rd Quarter Results
20th Nov 20241:00 pmRNSOffer Update
20th Nov 20241:00 pmRNSOffer Update
12th Nov 20241:52 pmRNSResult of General Meeting
1st Nov 202411:04 amRNSPayment of Dividend and Allotment of Shares
1st Nov 20247:00 amRNSOffer Update
1st Nov 20247:00 amRNSOffer Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.